Shengxian Quyu Decoction in the Treatment of Heart Failure With Reduced Ejection Fraction
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a multicenter, randomized clinical trial to evaluate
the effect of "Shengxian Quyu Decoction" on quality of life , symptoms, and biomarkers in
heart failure patients with reduced ejection fraction.